GSK analgesics was a big thing for a while, then just disappeared completely. Even completed a Phase 2 or whatever from memory.
Surface hygiene has been talked about for at least 5 years.
Coty was coming (2013), then not (2014), then coming (2015,16) now dead
Topical pain applicator coming by Christmas 2016.
Anyway the problem is that the applicators (W2) are nice but the volume is poor, and resale of said applicators isn't likely to be much.
The integrated products (W3/4?) are key for volume and repeat sales - the sooner we see that launched the better for the SP I think, even if the money isn't in the bank.
- Forums
- ASX - By Stock
- Someone has to ask this question
GSK analgesics was a big thing for a while, then just...
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online